Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: A multicentric study from India

Background : Outcome data of children with heart disease who acquired COVID-19 infection are limited. Aims : We sought to analyze outcome data and identify risk factors associated with mortality in children with heart disease and grown-ups with congenital heart disease (GUCH) who had a laboratory-confirmed COVID-19 infection. Settings and Design : This is a retrospective, multicentric, observational study. Materials and Methods : The study included children with heart disease and GUCH population, who presented with either symptomatic or asymptomatic COVID-19 infection to any of the participating centers. COVID-19-negative patients admitted to these centers constituted the control group. Results : From 24 pediatric cardiac centers across India, we included 94 patients with a median age of 12.5 (interquartile range 3–96) months and 49 (52.1%) patients were males. Majority (83 patients, 88.3%) were children. One-third of the patients (n = 31, 33.0%) had acyanotic congenital heart disease, and 41.5% (n = 39) were cyanotic, with > 80% of the patients being unoperated. Only 30 (31.9%) patients were symptomatic for COVID-19 infection, while the rest were incidentally detected positive on screening. A total of 13 patients died (case fatality rate: 13.8%). The in-hospital mortality rate among hospitalized patients was significantly higher among COVID-19-positive cases (13 of 48; 27.1%) as compared to COVID-negative admissions (9.2%) during the study period (P < 0.001). On multivariate analysis, the independent predictors of mortality among COVID-19-positive cases were severity of illness at admission (odds ratio [OR]: 535.7, 95% confidence interval [CI]: 6.9–41,605, P = 0.005) and lower socioeconomic class (OR: 29.5, 95% CI: 1.1–814.7, P = 0.046). Conclusions : Children with heart disease are at a higher risk of death when they acquire COVID-19 infection. Systematic preventive measures and management strategies are needed for improving the outcomes.

[1]  H. Nayak,et al.  Impact of COVID-19 pandemic on pediatric cardiac services in India , 2021, Annals of pediatric cardiology.

[2]  Andrew E. Williams,et al.  Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience , 2021, Pediatrics.

[3]  M. Schwerzmann,et al.  Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts , 2021, Open Heart.

[4]  M. Schwerzmann,et al.  COVID-19 in Adults With Congenital Heart Disease , 2021, Journal of the American College of Cardiology.

[5]  Pasquale Di Maio,et al.  Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study , 2021, Anaesthesia.

[6]  M. Schwerzmann,et al.  Clinical outcome of COVID-19 in patients with adult congenital heart disease , 2021, Heart.

[7]  Z. Bhutta,et al.  Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis , 2021, Archives of Disease in Childhood.

[8]  A. Saxena,et al.  Effect of acute lower respiratory tract infection on pulmonary artery pressure in children with post-tricuspid left-to-right shunt , 2021, Cardiology in the Young.

[9]  S. Mahmoudi,et al.  COVID-19 and congenital heart disease: a case series of nine children , 2021, World Journal of Pediatrics.

[10]  P. Lantz,et al.  Association of Social and Demographic Factors With COVID-19 Incidence and Death Rates in the US , 2021, JAMA network open.

[11]  M. Schwerzmann,et al.  Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease , 2020, European heart journal.

[12]  A. Eid,et al.  COVID-19 in Pediatric Patients: A Focus on CHD Patients , 2020, Frontiers in Cardiovascular Medicine.

[13]  J. Allaire,et al.  Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis , 2020, International Journal of Infectious Diseases.

[14]  M. Rodríguez-González,et al.  Cardiovascular impact of COVID-19 with a focus on children: A systematic review , 2020, World journal of clinical cases.

[15]  Jessica S. Brown,et al.  SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020. , 2020, MMWR. Morbidity and mortality weekly report.

[16]  J. Connors,et al.  The coagulopathy, endotheliopathy, and vasculitis of COVID-19 , 2020, Inflammation Research.

[17]  A. Ecevit,et al.  Management of congenital cardiac surgery during COVID-19 pandemic , 2020, Cardiology in the Young.

[18]  K. S. Iyer.  Impact of the COVID-19 pandemic on pediatric cardiac care in India: Time for action! , 2020, Annals of Pediatric Cardiology.

[19]  K. Mondy,et al.  Timing of surgery after recovery from coronavirus disease 2019 (COVID-19) infection , 2020, Infection Control & Hospital Epidemiology.

[20]  D. Leaf,et al.  COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection , 2020, Blood.

[21]  G. Di Salvo,et al.  COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey , 2020, Journal of clinical medicine.

[22]  A. Saxena,et al.  COVID-19 and Congenital Heart Disease: Perspectives From a Resource-limited Setting , 2020, Indian Pediatrics.

[23]  S. Nicolson,et al.  Considerations for Pediatric Heart Programs During COVID-19: Recommendations From the Congenital Cardiac Anesthesia Society , 2020, Anesthesia and analgesia.

[24]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[25]  M. Priestley,et al.  Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. , 2020, JAMA pediatrics.

[26]  E. Bacha,et al.  COVID-19: Crisis Management in Congenital Heart Surgery , 2020, The Annals of Thoracic Surgery.

[27]  Weiyi Tan,et al.  The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease , 2020, International Journal of Cardiology.

[28]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[29]  R. Wani.  Socioeconomic status scales-modified Kuppuswamy and Udai Pareekh's scale updated for 2019 , 2019, Journal of family medicine and primary care.

[30]  A. Saxena.  Congenital Heart Disease in India: A Status Report , 2018, Indian Pediatrics.

[31]  M. Gulati,et al.  Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions , 2018, Circulation.

[32]  S. Kothari.  Pediatric cardiac care for the economically disadvantaged in India: Problems and prospects , 2009, Annals of Pediatric Cardiology.

[33]  C. Medrano,et al.  Respiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic Study , 2007, Cardiology in the Young.

[34]  H. Brunner-La Rocca,et al.  Systemic Endothelial Dysfunction in Adults With Cyanotic Congenital Heart Disease , 2005, Circulation.

[35]  Kimberlee Gauvreau,et al.  Consensus-based method for risk adjustment for surgery for congenital heart disease. , 2002, The Journal of thoracic and cardiovascular surgery.